Germline BRCA1/2 variants cause hereditary breast and ovarian cancer syndrome and confer a lifetime risk of 38-87% of developing breast cancer in women and 16.5-63% of developing ovarian cancer (4). This evidence concerns the gene BRCA1 and ovarian carcinoma.